ASTM priced a public offering of 10,000,000 units Read more…
ASTM is commencing a public offering of its common stock and warrants. Read more…
ASTM plans to rapidly move Into a Phase 3 Program in 2011. Read more…
The NYSE dropped (11/16/10) 147 points while the NASDAQ dropped 43.98 and ASTM still rose; $4.41% ($4.28) to $4.28 at 10:55 am on 11/17/10. Read more…
ASTM will present data from an interim analysis of its Phase 2b RESTORE-CLI clinical trial at a VEITHsymposium™ non-CME satellite session. Read more…
ASTM is down 3.3% to $4.06 as it plans to sell as much as $75M in securities. Read more…
ASTM has been awarded 1 grant totaling $244K under the QTDP program. Read more…
ASTM’s net loss for Q1/11 was $5.83M or ($0.21) per share. Read more…
Reminder, ASTM’s earnings conference call is tomorrow (Monday – 11/8/10) at 9:30 am EST. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.